Nonlinear Algorithm Designed to Identify Risk of Sudden Cardiac Death


December 11, 2009

The PD2i Analyzer, which has FDA 510(k) marketing clearance, measures heart rate variability. The physicians performing diagnostic tests with the PD2i Analyzer are able to receive reimbursement under existing CPT codes.

Vicor Technologies created the noninvasive diagnostics system employing its patented, proprietary point correlation dimension algorithm (PD2i). The PD2i nonlinear algorithm is a deterministic, nonlinear measure of electrophysiological potentials to predict future pathological events, such as sudden cardiac death.

For more information: